Skip to main content
Year archive

Spyre Therapeutics, Inc. — 2022 filings

All 68 regulatory filings released by Spyre Therapeutics, Inc. (SYRE) in 2022, sourced directly from the official regulator.

68 Filings
2022 Period
2022 filings (68)
Filing Released Lang
8-K
Regulatory Filings
2022-12-19 English
FORM 4 SUBMISSION
Director's Dealing
2022-12-02 English
FORM 3 SUBMISSION
Director's Dealing
2022-12-02 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-12-01 English
8-K
Regulatory Filings
2022-11-30 English
8-K
Regulatory Filings
2022-11-15 English
10-Q
Interim / Quarterly Report Q3 2022
2022-11-03 English
8-K
Regulatory Filings
2022-11-03 English
8-K
Regulatory Filings
2022-10-04 English
8-K
Regulatory Filings
2022-09-06 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-26 English
FORM 3 SUBMISSION
Director's Dealing
2022-08-26 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-26 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-26 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-26 English
FORM 4 SUBMISSION
Director's Dealing
2022-08-26 English
8-K
Regulatory Filings
2022-08-25 English
8-K
Regulatory Filings
2022-08-18 English
10-Q
Interim / Quarterly Report Q2 2022
2022-08-04 English
8-K 2Q22
Regulatory Filings
2022-08-04 English
8-K
Regulatory Filings
2022-07-19 English
8-K
Regulatory Filings
2022-07-07 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-11 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
FORM 4 SUBMISSION
Director's Dealing
2022-06-10 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-06-09 English
8-K
Regulatory Filings
2022-06-08 English
8-K
Regulatory Filings
2022-06-02 English
8-K
Regulatory Filings
2022-05-20 English
424B5
Regulatory Filings
2022-05-20 English
424B5
Regulatory Filings
2022-05-06 English
8-K
Regulatory Filings
2022-05-06 English
FWP
Regulatory Filings
2022-05-05 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-05 English
8-K Q1 2022 RESULTS
Regulatory Filings
2022-05-05 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-21 English
8-K
Regulatory Filings
2022-04-12 English
FORM 4 SUBMISSION
Director's Dealing
2022-03-18 English
8-K
Regulatory Filings
2022-03-18 English
FORM 4 SUBMISSION
Director's Dealing
2022-03-15 English
FORM 4 SUBMISSION
Director's Dealing
2022-03-15 English
S-8
Regulatory Filings
2022-03-08 English
10-K
Annual Report FY 2021
2022-03-08 English
8-K
Regulatory Filings
2022-03-08 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-22 English
FORM 4 SUBMISSION
Director's Dealing
2022-02-22 English
FORM 5 SUBMISSION
Director's Dealing
2022-02-14 English
SCHEDULE 13G (AMENDMENT #2)
Major Shareholding Notification
2022-02-14 English
SC 13G
Major Shareholding Notification
2022-02-14 English
SC 13G/A
Major Shareholding Notification
2022-02-14 English
AMENDMENT NO. 5
Major Shareholding Notification
2022-02-11 English
SC 13D/A
Major Shareholding Notification
2022-02-10 English
SC 13G
Major Shareholding Notification
2022-02-10 English
8-K
Regulatory Filings
2022-02-10 English
AEGLEA BIOTHERAPEUTICS, INC.
Major Shareholding Notification
2022-02-10 English
8-K
Regulatory Filings
2022-02-09 English
424B5
Regulatory Filings
2022-02-09 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-03 English
8-K
Regulatory Filings
2022-01-05 English